Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

PARP-1/2 inhibition enhances chemotherapeutics' antitumor effect

May 14, 2015

Novel ERK inhibitor active in MAPK pathway-dependent cancers

May 14, 2015

Protease-activated fluorescent agent images residual disease during surgery

May 14, 2015

Intravitreal CD34+ autologous bone marrow-derived cells safe in dry AMD patients

May 13, 2015

PIM-447 shows potential for the treatment of MM

May 13, 2015

Data on REGN-844 for dry eye disease reported

May 13, 2015

NAPs show promising sequence-independent antiviral activity

May 13, 2015

NO-donating bimatoprost shows preclinical efficacy reducing IOP

May 13, 2015

Pre-amplification improves SNP genotype assays with hair and saliva samples

May 12, 2015

Same autoantibodies seen in retinitis pigmentosa models and patients with MERTK mutations

May 12, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.